Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.15 - $4.0 $11,752 - $313,392
78,348 Added 578.68%
91,887 $17,000
Q3 2022

Nov 14, 2022

BUY
$0.19 - $3.8 $2,572 - $51,448
13,539 New
13,539 $3,000
Q3 2021

Nov 16, 2021

SELL
$2.78 - $5.12 $43,701 - $80,486
-15,720 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$4.73 - $7.56 $74,355 - $118,843
15,720 New
15,720 $78,000

Others Institutions Holding AYTU

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About AYTU BIOPHARMA, INC


  • Ticker AYTU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 62,432,700
  • Market Cap $88.7M
  • Description
  • Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...
More about AYTU
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.